Healthcare Services

Female Infertility Market (2026–2030): Industry Developments

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Level Of Market Value Growth Is Predicted For The Female Infertility Market From 2026 To 2030?

The female infertility market’s size has demonstrated consistent growth in recent years. Looking ahead, it is projected to expand from $1.86 billion in 2025 to $1.94 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 4.1%. The expansion observed in the historical period was driven by factors such as delayed childbearing trends, heightened awareness of infertility, the availability of fertility drugs, the proliferation of reproductive health clinics, and advancements in diagnostic imaging.

The female infertility market is projected to experience consistent expansion over the upcoming years. By 2030, its valuation is anticipated to reach $2.26 billion, demonstrating a compound annual growth rate (CAGR) of 3.8%. This anticipated growth is primarily driven by progress in fertility drug compositions, the rise of individualized fertility care, greater implementation of AI-powered fertility tracking solutions, the spread of fertility tourism, and increasing investments in reproductive health initiatives. Significant developments expected during this period encompass a growing need for assisted reproductive treatments, a heightened emphasis on therapies targeting hormones and ovulation, the wider application of sophisticated diagnostic methods, the proliferation of fertility clinics and related services, and the incorporation of digital platforms into fertility management.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/female-infertility-global-market-report

Which Important Drivers Are Guiding The Female Infertility Market Growth?

The increasing incidence of infertility is projected to fuel the expansion of the female infertility market. Infertility refers to the inability to conceive after 12 months of regular, unprotected sexual intercourse. This rise in infertility is attributed to several factors such as delayed childbearing, changes in lifestyle, exposure to environmental toxins, escalating obesity rates, and elevated stress levels. Female infertility treatment is necessary to address and manage underlying medical, hormonal, or structural issues that impede fertility, thereby enhancing the chances of conception and preventing permanent infertility. For instance, in April 2023, according to the World Health Organization, a Switzerland-based intergovernmental organization, approximately 17.5% of the global adult population, or about 1 in 6 individuals, confront infertility. Consequently, the rising prevalence of infertility acts as a key driver for the growth of the female infertility market.

Which Segment Classifications Are Used In The Female Infertility Market Segment Analysis?

The female infertility market covered in this report is segmented –

1) By Treatment: Clomiphene Citrate, Gonadotropins, Metformin, Letrozole, Bromocriptine

2) By Route Of Administration: Oral, Parenteral, Other Route Of Administrations

3) By End-User: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Clomiphene Citrate: Oral Clomiphene Citrate, Injectable Clomiphene Citrate

2) By Gonadotropins: Recombinant Gonadotropins, Urinary Gonadotropins, Human Chorionic Gonadotropin (hCG)

3) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

4) By Letrozole: Oral Letrozole Tablets, Injectable Letrozole

5) By Bromocriptine: Oral Bromocriptine Tablets, Intranasal Bromocriptine

What Trends Are Influencing The Evolution Of The Female Infertility Market?

Leading companies operating in the female infertility market are concentrating on developing novel products, such as non-invasive diagnostic tests, to gain a competitive advantage in the industry. A non-invasive diagnostic test is a medical examination that identifies conditions or diseases without needing surgery or bodily penetration. For instance, in August 2024, Heranova Lifesciences, a US-based biotech firm, launched an early access program for HerResolve, a non-invasive diagnostic test designed for endometriosis. Endometriosis impacts approximately 200 million women globally, causing symptoms including infertility, pain, and bleeding. For numerous women, an accurate diagnosis typically takes 7-10 years from the initial onset of symptoms, mainly due to the varied symptom presentation and the invasive nature of the most dependable diagnostic approach, exploratory laparoscopic surgery. HerResolve has the potential to reduce this diagnostic delay from years to mere months, resulting in improved patient and healthcare outcomes. HerResolve aims to significantly decrease this timeline, thereby enhancing patient care and outcomes.

Which Firms Are Contributing To The Female Infertility Market Ecosystem?

Major companies operating in the female infertility market are Pfizer Inc, Merck And Co Inc, Mayo Clinic, Teva Pharmaceutical Industries Ltd, Organon Theramex, Juniper Reproductive Health Ltd, Ferring Pharmaceuticals, Mankind Pharma, ARMC IVF, Zydus Cadila Healthcare, IBSA Institut Biochimique, Oxolife, Ava AG, Merck KGaA, Gedeon Richter Plc, Novartis AG, AbbVie Inc, Ipsen, Theramex, Vitrolife AB, Conceivable Life Sciences, AIVF

Get The Full Female Infertility Market Report:

https://www.thebusinessresearchcompany.com/report/female-infertility-global-market-report

Which Region Is The Largest In The Female Infertility Market?

Europe was the largest region in the female infertility market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the female infertility market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Female Infertility Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/female-infertility-global-market-report

Browse Through More Reports Similar to the Global Female Infertility Market 2026, By The Business Research Company

Fertility Treatments Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report

Male Fertility Market Report 2026

https://www.thebusinessresearchcompany.com/report/male-fertility-global-market-report

Fertility Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/fertility-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795